Xtrackers MSCI World Ex Usa UCITS ETF (SWX:EXUS)
Switzerland
· Delayed Price · Currency is CHF 28.29
+0.11 (0.39%)
At close: Apr 25, 2025, 5:20 PM CET
2.07% (1Y)
| Assets | 1.68B |
| Expense Ratio | 0.15% |
| PE Ratio | 15.18 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 6,632 |
| Open | 28.51 |
| Previous Close | 28.18 |
| Day's Range | 28.25 - 28.51 |
| 52-Week Low | 24.85 |
| 52-Week High | 30.62 |
| Beta | n/a |
| Holdings | 767 |
| Inception Date | Mar 6, 2024 |
About EXUS
EXUS.L was created on 2024-03-06 by Xtrackers. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 1511.13m in AUM and 777 holdings. The fund is passively managed. DESCRIPTION OF INDEX: The aim is for your investment to track the performance, before fees and expenses, of the MSCI World ex USA Index (index) which is designed to reflect the performance of companies from global developed markets, excluding the United States of America.
Asset Class Equity
Category Total Market
Stock Exchange SIX Swiss Exchange
Ticker Symbol EXUS
Provider Xtrackers
Index Tracked MSCI World ex USA
Top 10 Holdings
12.18% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 1.46% |
| SAP SE | SAP | 1.42% |
| Nestlé S.A. | NESN | 1.35% |
| Novo Nordisk A/S | NOVO.B | 1.29% |
| Roche Holding AG | ROG | 1.23% |
| AstraZeneca PLC | AZN | 1.19% |
| Novartis AG | NOVN | 1.11% |
| Shell plc | SHEL | 1.09% |
| HSBC Holdings plc | HSBA | 1.05% |
| Siemens Aktiengesellschaft | SIE | 0.99% |